18 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:19am
to manage our exposure to digital threats and strengthen adherence to compliance and data privacy standards across our online channels. Our significant
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
Conditions Preventing Drug Resistance Counterfeit Drug Program Tax Transparency Lifelong Learning Speed of Product Development Data Privacy & Security
6-K
EX-99.1
nw07aum8i t520
17 Dec 20
Current report (foreign)
6:01am
6-K
md4w zfyxsfzryjn1z1
29 May 20
Current report (foreign)
6:20am
6-K
EX-99.1
0piyq4nbw fc4
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
424B3
tjyzvzr
14 Nov 19
Prospectus supplement
6:10am
F-4/A
heqhg9 54vx7u
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
e3p 4g43s
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
qaw6s7v9fzfm7t6r
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
qocbe
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
sdz9vfgc qe
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
pk35u
16 Nov 18
Draft registration statement (amended)
12:00am
SC TO-T
EX-99
x7pw5x75e5ana jvrrd
30 Apr 18
Third party tender offer statement
6:13am
- Prev
- 1
- Next